electroCore, Inc.
NASDAQ:ECORMedical - Devices
-$0.50 today
- Market cap
- $71.13M
- Beta
- 0.87
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.72
Volume 0.06M
Average 0.11M
ECOR EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
electroCore, Inc.NASDAQ: ECOR
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) remains negative
Q1 FY2026 EPS (Diluted) was -$0.59, compared with -$0.47 a year earlier. Trailing-twelve-month EPS (Diluted) was -$1.81.
Context
- EPS (Diluted) grew in size in 1 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 4 analysts of -$1.38 (+16.6%) for the fiscal year ending Dec 2026, a step up from the -3.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.59-55.3% QoQ
- Last fiscal yearDec 2025
- -$1.65-3.8% YoY
- LTMMar 2026
- -$1.81-13.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -25.5% | +4.1% | +29.7 pp |
| 1 year | -3.8% | +16.6% | +20.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- (1.65) USD
- Year-over-year change
- -3.8%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.65) | -3.8% |
| FY2024 | 2024-12-31 | (1.59) | +53.5% |
| FY2023 | 2023-12-31 | (3.42) | +27.1% |
| FY2022 | 2022-12-31 | (4.69) | -7.6% |
| FY2021 | 2021-12-31 | (4.36) | — |
EPS (Diluted) vs competitors
How ECOR compares with its peers on the latest reported figures
- ECOR's LTM Mar 2026 EPS (Diluted) of -$1.81 is the 4th highest of the 6 companies compared; the peer median is -$0.68.
- Its year-over-year change of -13.8% is the 5th highest of 6, against a peer median of +17.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | -$0.34 | +17.3% | — | |
| LTM Mar 2026 | -$0.36 | -147.2% | — | |
| LTM Mar 2026 | -$0.68 | +15.6% | — | |
| LTM Mar 2026 | -$1.81 | -13.8% | — | |
| LTM Mar 2026 | -$1.91 | +55.6% | — | |
| LTM Jun 2026 | -$3.22 | +93.1% | — | |
| Peer median (excluding ECOR) | -$0.68 | +17.3% | — | |
Competitors are the stored peer set for ECOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.45M | 8.59M | 16.03M | 25.18M | 32.03M |
| Cost of Revenue | 1.39M | 1.62M | 2.8M | 3.79M | 4.24M |
| Gross Profit | 4.07M | 6.98M | 13.23M | 21.4M | 27.79M |
| Gross Margin | 74.6% | 81.2% | 82.5% | 85.0% | 86.8% |
| Research & Development | 2.54M | 5.52M | 5.32M | 2.36M | 2.74M |
| Selling, General & Admin | 21.57M | 24.33M | 26.71M | 31.2M | 38.21M |
| Operating Expenses | 24.11M | 29.85M | 32.03M | 33.56M | 40.94M |
| Depreciation & Amortization | 382K | 596K | 1.26M | 1.26M | 1.68M |
| EBITDA | (17.69M) | (22M) | (17.76M) | (10.72M) | (11.7M) |
| EBITDA Margin | -324.5% | -256.0% | -110.8% | -42.6% | -36.5% |
| Operating Income | (20.04M) | (22.87M) | (18.81M) | (12.16M) | (13.15M) |
| Operating Margin | -367.7% | -266.2% | -117.3% | -48.3% | -41.1% |
| Interest Income | 11K | 287K | 433K | 572K | 298K |
| Interest Expense | 0 | 0 | 0 | 0 | 590K |
| Other Income / Expenses | 1.97M | 281K | (215K) | 183K | (810K) |
| Income Before Tax | (18.07M) | (22.59M) | (19.02M) | (11.98M) | (13.96M) |
| Pre-Tax Margin | -331.5% | -263.0% | -118.7% | -47.6% | -43.6% |
| Income Tax Expense | (851K) | (431K) | (186K) | (93K) | 3K |
| Net Income | (17.22M) | (22.16M) | (18.83M) | (11.89M) | (13.97M) |
| Net Margin | -315.9% | -257.9% | -117.5% | -47.2% | -43.6% |
| EPS (Basic) | (4.36) | (4.69) | (3.42) | (1.59) | (1.65) |
| EPS (Diluted) | (4.36) | (4.69) | (3.42) | (1.59) | (1.65) |
| Weighted Avg Shares | 3.95M | 4.73M | 5.52M | 7.48M | 8.48M |
| Weighted Avg Shares (Diluted) | 3.95M | 4.73M | 5.52M | 7.48M | 8.48M |
electroCore, Inc.
NASDAQ:ECOR
Intrinsic Alpha fair value
Locked
Current Price
$7.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.